The global anticoagulants market size attained a value of USD 37.65 Billion in 2024 driven by growing lifestyle risks like diabetes and obesity, along with the growing health awareness among the public, currently require better and efficient treatments. The market is anticipated to grow at a CAGR of 8.20% during the forecast period of 2025-2034 to attain a value of USD 82.80 Billion by 2034.
Base Year
Historical Period
Forecast Period
Compound Annual Growth Rate
8.2%
Value in USD Billion
2025-2034
Anticoagulants Market Outlook
*this image is indicative*
North America is one of the major markets in the anticoagulants industry. This can be attributed to the increase in the incidence rate of cardiovascular diseases in North America. According to Centres for Disease Control and Prevention, one in every 4 deaths is caused by heart disease, i.e., about 655,000 Americans die from heart disease each year. Further, a well-established healthcare infrastructure, along with the presence of key pharma and biotech companies, is supporting the entire regional market's expansion to a great extent.
Europe is also a significant contributor to the anticoagulants industry. According to the European Society of Cardiology (ESC), the region witnesses more than 11 million new cases of cardiovascular diseases (CVD) on the whole every year, as per 2019 statistics. In the EU, about 49 million people are currently living with this condition. Further, as per ESC, CVD is the leading cause of death in Europe, accounting for about 45% of all deaths and 37% in the EU. Meanwhile, major countries in the Asia Pacific, such as China, are also rising cases of CVD. China is witnessing an increasing mortality rate attributed to CVD. In 2016, as reported by the Journal of Geriatric Cardiology, cardiovascular disease (CVD) was the top cause of mortality in both rural and urban areas, accounting for 45.50% and 43.16% of all deaths, respectively. This is likely to make China an emerging market for anticoagulants in the forecast period.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Anticoagulants are referred to as those drugs that prevent the formation of blood clots. They're given to those who have a high risk of blood clots to help them avoid catastrophic diseases, including strokes and heart attacks. Anticoagulants act by inhibiting the process that causes the formation of blood clots. They are also known as "blood thinners".
Market Breakup by Drug Class
Market Breakup by Application
Market Breakup by Route of Administration
Market Breakup by Region
The growing lifestyle risks like diabetes and obesity, along with the growing health awareness among the public, currently require better and efficient treatments. The introduction of NOACs has resulted in a significant increase in anticoagulant use and expenditure. The development of pharmaceuticals and therapeutic companies is boosting the production and efficiency of anticoagulants. This is augmenting the market growth of anticoagulants. The risks and threats for health posed by COVID-19 have boosted investments in the anticoagulant industry. The growing healthcare expenditure by the government, along with key market players, is a huge driving force for the market. There are strict government regulations attributed to the safety and dosage of anticoagulants. The FDA approval of anticoagulants usage for paediatric heart patients in 2019 is also a huge boost to the industry.
The report presents a detailed analysis of the following key players in the global anticoagulants market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Upto 15% Off
USD
$5499 $4949
$3299 $2969
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Globally, anticoagulants market reached a value of USD 37.65 Billion in 2024.
The market is projected to expand at a CAGR of 8.20% from 2025 to 2034, growing to USD 82.80 Billion by 2034.
The growing incidence of cardiovascular diseases, growing lifestyle risks, and growing health awareness are leading the market growth.
The adoption of more efficient and safer anticoagulants like NOACs is expected to influence the market over the forecast period.
The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The different drug classes of anticoagulants are novel oral anticoagulants (NOACs), heparin and low molecular weight heparin (LMWH), vitamin K antagonist.
The anticoagulants find its applications in the treatment of atrial fibrillation/myocardial infarction (heart attack), and deep vein thrombosis (DVT), and pulmonary embolism, among others.
The major players in the industry are Johnson & Johnson Services, Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Limited, GlaxoSmithKline plc, Aspen Pharmacare Holdings Limited, Pfizer Inc., and Portola Pharmaceuticals, Inc., among others.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Drug Class |
|
| Breakup by Application |
|
| Breakup by Route of Administration |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
